By complementing life science marketing strategies with Facebook Live, companies will be able to connect with and engage more people in a more familiar and direct manner, which will drive digital word-of-mouth.
Doctors in the Northwest are once again rethinking aid-in-dying medications because they’re taking too long to work.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Calling Aurinia Pharmaceuticals one happy customer of Philadelphia clinical trial analytics provider Prevail InfoWorks is a gross understatement.
The renewed interest in compassionate use — which first emerged as a national issue during the AIDS crisis of the 1980s — also has spurred pharmaceutical companies to ramp up “expanded access” programs.
Exondys 51 doesn’t cure Duchenne muscular dystrophy and will only help a minority of patients.
MyTomorrows has had its greatest success in Europe, but is looking forward to bringing its services to the U.S.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Drug prices are rising again and consumers, faced with higher out-of-pocket costs, are turning to lawmakers for help.
Only last year PillPack raised $50 million from investors such as Charles River Ventures, Menlo Ventures and Sherpa Ventures alongside Accel Partners and Atlas Venture
In an outcomes-driven environment, focusing on patients is key but value needs to be demonstrated for all stakeholders when adopting new strategies to go beyond the pill.
We find the most value in niche companies that can perform one particular service better than anyone else.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Open payments data shows that Novartis shelled out the most to physicians in 2015 - a total of $540 million. Who followed the drugmaker?
Drug pricing was destined to be a major topic, as manufacturers and payers continue to duke it out.
Also, Color Genomics expands its genetic test portfolio and Apple rolls out first clinical apps developed with CareKit.
Some examples of how pharma companies are using social media to boost the drug industry's 1 percent industrial annual growth rate.
Also, an outbreak of VIP syndrome at hospitals, fashionable prosthetics and Samsung's advancement of biosimilar drug for rheumatoid arthritis.